Reasonable Rx PDF Download
Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download Reasonable Rx PDF full book. Access full book title Reasonable Rx by Stan Finkelstein. Download full books in PDF and EPUB format.
Author: Stan Finkelstein
Publisher: FT Press
ISBN: 0132703998
Category : Business & Economics
Languages : en
Pages : 207
Get Book Here
Book Description
A Real Plan for Making Drugs Affordable–and Promoting Innovation, Too “This book is a necessity for understanding the pharmaceutical industry. Both the pluses and minuses of the present system are set forth with a judicious combination of historical narrative, economic analysis, and statistical data. The highly original proposals for reform will be a major stimulant to analysis and policy-making.” –Kenneth Arrow, Nobel Laureate in Economics, Professor Emeritus, Stanford University “This is a timely book by authors who know what they are talking about. They tackle a big problem: rising drug prices that are threatening to overwhelm us all–and especially those with limited or absent health care insurance. Will we drive people overseas for healthcare? Will there be social unrest? This book describes the problem and then offers a solution. Worth a careful read by everyone, pharmaceutical manufacturers and government policymakers especially.” –Roger Williams, M.D., Chief Executive Officer of the United States Pharmacopeia and a former senior official of the Food and Drug Administration “This book confounds two sets of skeptics: Those who say there’s no way to resolve the conflict between the need to fund pharmaceutical research and our desire to keep medicine affordable; and those who think that economics never has anything good to say.” –Honorable Barney Frank, Congressman from Massachusetts “This book comes at the right time and could become the starting point of discussions, which will eventually lead us into new era in the healthcare care industry. It will without a doubt become a must for insiders of the pharma- and biotech industries.” –Dr. Jürgen Drews, retired President of Roche Pharmaceutical Group Global Research Acknowledgments viii About the Authors ix Introduction xi Chapter 1: Drugs and Drug Prices 1 Chapter 2: The American Way to Discover Drugs 21 Chapter 3: The Drug Industry Today 39 Chapter 4: Are Drug Companies Risky? 59 Chapter 5: How Not to Lower Drug Prices 77 Chapter 6: Squandering R & D Resources 103 Chapter 7: How to Lower Drug Prices 129 Appendix: Our Solution in Detail 155 Index 177
Author: Stan Finkelstein
Publisher: FT Press
ISBN: 0132703998
Category : Business & Economics
Languages : en
Pages : 207
Get Book Here
Book Description
A Real Plan for Making Drugs Affordable–and Promoting Innovation, Too “This book is a necessity for understanding the pharmaceutical industry. Both the pluses and minuses of the present system are set forth with a judicious combination of historical narrative, economic analysis, and statistical data. The highly original proposals for reform will be a major stimulant to analysis and policy-making.” –Kenneth Arrow, Nobel Laureate in Economics, Professor Emeritus, Stanford University “This is a timely book by authors who know what they are talking about. They tackle a big problem: rising drug prices that are threatening to overwhelm us all–and especially those with limited or absent health care insurance. Will we drive people overseas for healthcare? Will there be social unrest? This book describes the problem and then offers a solution. Worth a careful read by everyone, pharmaceutical manufacturers and government policymakers especially.” –Roger Williams, M.D., Chief Executive Officer of the United States Pharmacopeia and a former senior official of the Food and Drug Administration “This book confounds two sets of skeptics: Those who say there’s no way to resolve the conflict between the need to fund pharmaceutical research and our desire to keep medicine affordable; and those who think that economics never has anything good to say.” –Honorable Barney Frank, Congressman from Massachusetts “This book comes at the right time and could become the starting point of discussions, which will eventually lead us into new era in the healthcare care industry. It will without a doubt become a must for insiders of the pharma- and biotech industries.” –Dr. Jürgen Drews, retired President of Roche Pharmaceutical Group Global Research Acknowledgments viii About the Authors ix Introduction xi Chapter 1: Drugs and Drug Prices 1 Chapter 2: The American Way to Discover Drugs 21 Chapter 3: The Drug Industry Today 39 Chapter 4: Are Drug Companies Risky? 59 Chapter 5: How Not to Lower Drug Prices 77 Chapter 6: Squandering R & D Resources 103 Chapter 7: How to Lower Drug Prices 129 Appendix: Our Solution in Detail 155 Index 177
Author: National Academies of Sciences, Engineering, and Medicine
Publisher: National Academies Press
ISBN: 0309468086
Category : Medical
Languages : en
Pages : 235
Get Book Here
Book Description
Thanks to remarkable advances in modern health care attributable to science, engineering, and medicine, it is now possible to cure or manage illnesses that were long deemed untreatable. At the same time, however, the United States is facing the vexing challenge of a seemingly uncontrolled rise in the cost of health care. Total medical expenditures are rapidly approaching 20 percent of the gross domestic product and are crowding out other priorities of national importance. The use of increasingly expensive prescription drugs is a significant part of this problem, making the cost of biopharmaceuticals a serious national concern with broad political implications. Especially with the highly visible and very large price increases for prescription drugs that have occurred in recent years, finding a way to make prescription medicinesâ€"and health care at largeâ€"more affordable for everyone has become a socioeconomic imperative. Affordability is a complex function of factors, including not just the prices of the drugs themselves, but also the details of an individual's insurance coverage and the number of medical conditions that an individual or family confronts. Therefore, any solution to the affordability issue will require considering all of these factors together. The current high and increasing costs of prescription drugsâ€"coupled with the broader trends in overall health care costsâ€"is unsustainable to society as a whole. Making Medicines Affordable examines patient access to affordable and effective therapies, with emphasis on drug pricing, inflation in the cost of drugs, and insurance design. This report explores structural and policy factors influencing drug pricing, drug access programs, the emerging role of comparative effectiveness assessments in payment policies, changing finances of medical practice with regard to drug costs and reimbursement, and measures to prevent drug shortages and foster continued innovation in drug development. It makes recommendations for policy actions that could address drug price trends, improve patient access to affordable and effective treatments, and encourage innovations that address significant needs in health care.
Author: Gretchen M. Lentz
Publisher: Elsevier Health Sciences
ISBN: 032306986X
Category : Medical
Languages : en
Pages : 957
Get Book Here
Book Description
In the 25 years since the first edition of Comprehensive Gynecology, many scientific advances have occurred in medical practice. The first four editions were largely the work of the original four editors: Drs. William Droegemueller, Arthur L. Herbst, Daniel R. Mishell, Jr., and Morton A. Stenchever...With the staggering volume of medical literature published and the complexities of the gynecologic subspecialties, we have collaborated with additional experts for the sixth edition. We've "examined disease" and added a new chapter on the interaction of medical diseases and female physiology. We've "investigated discord" with new authors to completely rewrite the emotional and psychological issues in gynecology and the legal issues for obstetrician-gynecologists. Other chapters have delved into the controversies in breast cancer screening, vitamin D use, the ongoing debates in hormone therapy, and vaginal mesh use for pelvic organ prolapse surgery. (from Preface -- MD Consult, viewed April 9, 2012)
Author: Gretchen M Lentz
Publisher: Elsevier Health Sciences
ISBN: 0323091318
Category : Medical
Languages : en
Pages : 1084
Get Book Here
Book Description
Comprehensive Gynecology provides you with complete, timely, and easy access to vital information on all the medical and surgical issues affecting your practice. Whether you’re a resident or practioner, you’ll get all the practical, in-depth coverage you need to stay at the forefront of your field. Now in its sixth edition, this core reference, formerly edited by Drs. Droegemueller, Stenchever, Mishell and Herbst, continues to be your primary resource for in-depth and up-to-date information. Stay up to date with the latest gynecologic advances through clear writing, a clinical focus, and a focus on evidence-based practices. Prepare for the challenges you’ll face in practice with a completely overhauled legal chapter containing factual scenarios. Stay current in your field with the most recent advances in breast care; endoscopy and hysteroscopy; menopausal bone health; legal issues affecting our practice; and much more. Access state-of-the-art guidance on the latest applications in diagnostic and interventional ultrasound - and many other essential aspects of today's practice - through detailed sections on the molecular biology of specific gynecologic malignancies and a new chapter on Fallopian Tube and Primary Peritoneal Cancer. Recognize the interactions and influences of female physiology on major disease processes with a new chapter on The Interaction of Medical Diseases and Female Physiology. Address every patient’s needs with the Emotional Issues in Gynecology chapter, now modified in partnership with a psychiatrist, and updated information on depression/anxiety treatment.
Author: John T. Daugirdas
Publisher: Lippincott Williams & Wilkins
ISBN: 1451165919
Category : Medical
Languages : en
Pages : 806
Get Book Here
Book Description
The revised, updated Fourth Edition of this popular handbook provides practical, accessible information on all aspects of dialysis, with emphasis on day-to-day management of patients. Chapters provide complete coverage of hemodialysis, peritoneal dialysis, special problems in dialysis patients, and problems pertaining to various organ systems. This edition reflects the latest guidelines of the National Kidney Foundation's Kidney Disease Outcomes Quality Initiative (KDOQI) on hemodialysis and peritoneal dialysis adequacy and on nutrition. New chapters cover chronic kidney disease management in predialysis patients, frequent daily or nocturnal hemodialysis, and hemodiafiltration. Chapters on venous and arteriovenous access have been completely revised. Each chapter provides references to relevant Web sites.
Author: Jean Paul Gagnon
Publisher:
ISBN:
Category : Pharmaceutical services
Languages : en
Pages : 80
Get Book Here
Book Description
Author: Joint Commission on Prescription Drug Use
Publisher:
ISBN:
Category : Drug utilization
Languages : en
Pages : 264
Get Book Here
Book Description
Author: Thomas Arnold Herbert
Publisher:
ISBN:
Category : Medicine
Languages : en
Pages : 244
Get Book Here
Book Description
Author: K P E Lasok KC
Publisher: Bloomsbury Publishing
ISBN: 1526519771
Category : Law
Languages : en
Pages : 1899
Get Book Here
Book Description
When the European Court of Justice and the Court of First Instance drafts its own procedural rules, and when it makes decisions on procedural matters, it turns to the highly regarded Lasok's European Court Practice and Procedure for confirmation and guidance. Fully revised and updated the fourth edition: 1. Explains the implications of Brexit and the residual jurisdiction of the ECJ in relation to the UK under the Withdrawal Agreement. 2. Takes account of and provide in-depth analysis of all case law since the previous edition. 3. Provides guidance on the new General Court Rules of Procedure. 4. Provides new commentary on the Judges and Advocates General caused by Brexit and the current ongoing litigation concerning Advocate General Sharpston. 5. Includes additional commentary on the confidentiality regime for cases raising security concerns. Written by the internationally acknowledged expert in this area of law Lasok's European Court Practice and Procedure is the leading and must have work for anyone preparing a case to be heard before the European Court of Justice. This title is included in Bloomsbury Professional's Practice and Procedure online service.
Author: United States. Securities and Exchange Commission
Publisher:
ISBN:
Category : Securities
Languages : en
Pages : 2456
Get Book Here
Book Description
